Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Virginia Bioinformatics Institute

The Biocomplexity Institute of Virginia Tech (formerly the Virginia Bioinformatics Institute) is a research organization specializing in bioinformatics, computational biology, and systems biology. The Institute has more than 250 personnel, including over 50 tenured and research faculty. Research at the Institute involves collaboration in diverse disciplines such as mathematics, computer science, biology, plant pathology, biochemistry, systems biology, statistics, economics, synthetic biology and medicine. The Institute opened in July 2000 in space at the Virginia Tech Corporate Research Centre. Our mission is Where conceptual and technological constraints once forced researchers to examine living systems one small slice at a time, we can now find complex connections ranging from the basic building blocks of life to public policy. The complexity and scale of research at the Biocomplexity Institute of Virginia Tech demands coordination between experts in many different fields: mathematics, biology, physics, computer science, statistics, psychology and more. Our approach of taking complex problems as they occur in the world requires teaming as a practical necessity. Teaming becomes an organizational philosophy that allows faculty to explore new applications of their various expertise. current research agenda is defined by distinct thematic lines associated with our four primary laboratories: the Network Dynamics and Simulation Science Laboratory, Social and Decision Analytics Laboratory, Nutritional Immunology and Molecular Medicine Laboratory, and Mathematical Biocomplexity Laboratory. award-winning faculty hails from all over the globe. Together, they have found new markers for cancer, modeled the spread of deadly diseases, and developed new tools to accelerate the pace of scientific discovery.